Copeptin, a C-terminal part of the precursor pre-provasopressin is a novel biomarker of arginine-vasopressin (AVP) system. Measurements of AVP concentration are not used in clinical practice because of technical difficulties. Copeptin is synthesized in stoichiometric ratio with AVP, hence it reflects vasopressin concentration in human plasma and serum. This review outlines current research concerning the role of copeptin as a prognostic marker in different diseases and its potential clinical value.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.advms.2015.07.002 | DOI Listing |
Publication Analysis
Top Keywords
potential clinical
8
copeptin
4
copeptin pathophysiology
4
pathophysiology potential
4
clinical impact
4
impact copeptin
4
copeptin c-terminal
4
c-terminal precursor
4
precursor pre-provasopressin
4
pre-provasopressin novel
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!